Dr Walter Lovell Bogart Iii, MD | |
650 Huebner Rd, Fort Riley, KS 66442-4030 | |
(852) 393-6277 | |
Not Available |
Full Name | Dr Walter Lovell Bogart Iii |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Location | 650 Huebner Rd, Fort Riley, Kansas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1922084151 | NPI | - | NPPES |
180042973 | Other | SC | RAILROAD MEDICARE |
142036 | Medicaid | SC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 14203 (South Carolina) | Primary |
Entity Name | Bend Memorial Clinic Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1699827477 PECOS PAC ID: 7214936533 Enrollment ID: O20061215000022 |
News Archive
An international team of scientists from Nanyang Technological University, Singapore (NTU Singapore), Brown University and the Massachusetts Institute of Technology (MIT) has developed an artificial intelligence (AI) platform that could one day be used in a system to assess vascular diseases, which are characterised by the abnormal condition of blood vessels.
Researchers have identified the gene that ultimately controls the production of tooth enamel, a significant advance that could some day lead to the repair of damaged enamel, a new concept in cavity prevention, and restoration or even the production of replacement teeth.
Galacto-oligosaccharides are essentially sugar or saccharide molecules that have been joined together into short polymer chains.
Young people's satisfaction with their family situation is clearly related to the quality of relationships with parents and especially their mother's happiness. The research findings come from the first findings from Understanding Society, the world's largest household panel study managed by the Institute for Social and Economic Research at the University of Essex.
Cardio3 BioSciences, a leader in the discovery and development of engineered cell therapies, today confirmed plans to open a new U.S.-based manufacturing facility in Rochester, Minnesota. The facility will support the Company's current and anticipated manufacturing needs in the United States for both the Phase III clinical trial evaluating lead cardiovascular product candidate C-Cure (CHART-2), and its recently acquired CAR T-cell therapies' portfolio.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Walter Lovell Bogart Iii, MD 603 Bimini Twist Cir Ste C, Lexington, SC 29072-6725 Ph: () - | Dr Walter Lovell Bogart Iii, MD 650 Huebner Rd, Fort Riley, KS 66442-4030 Ph: (852) 393-6277 |
News Archive
An international team of scientists from Nanyang Technological University, Singapore (NTU Singapore), Brown University and the Massachusetts Institute of Technology (MIT) has developed an artificial intelligence (AI) platform that could one day be used in a system to assess vascular diseases, which are characterised by the abnormal condition of blood vessels.
Researchers have identified the gene that ultimately controls the production of tooth enamel, a significant advance that could some day lead to the repair of damaged enamel, a new concept in cavity prevention, and restoration or even the production of replacement teeth.
Galacto-oligosaccharides are essentially sugar or saccharide molecules that have been joined together into short polymer chains.
Young people's satisfaction with their family situation is clearly related to the quality of relationships with parents and especially their mother's happiness. The research findings come from the first findings from Understanding Society, the world's largest household panel study managed by the Institute for Social and Economic Research at the University of Essex.
Cardio3 BioSciences, a leader in the discovery and development of engineered cell therapies, today confirmed plans to open a new U.S.-based manufacturing facility in Rochester, Minnesota. The facility will support the Company's current and anticipated manufacturing needs in the United States for both the Phase III clinical trial evaluating lead cardiovascular product candidate C-Cure (CHART-2), and its recently acquired CAR T-cell therapies' portfolio.
› Verified 4 days ago
Dr. Aaron Michael Wold, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 650 Huebner Rd, Fort Riley, KS 66442 Phone: 785-239-3627 | |
Klaus Freeland, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 600 Caisson Hill Rd, Fort Riley, KS 66442 Phone: 785-240-7335 |